Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · Real-Time Price · USD

6.34

-0.56 (-8.12%)

At close: May 18, 2026, 4:00 PM EDT

6.32

-0.02 (-0.32%)

Pre-market: May 19, 2026, 5:32 AM EDT

Relmada Therapeutics Employees

Relmada Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year.

Employees

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

n/a

Profits / Employee

-$3,463,391

Market Cap

664.99M

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	17	0	-
Dec 31, 2024	17	-3	-15.00%
Dec 31, 2023	20	6	42.86%
Dec 31, 2022	14	4	40.00%
Dec 31, 2021	10	-4	-28.57%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jun 30, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jun 30, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jun 30, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jun 30, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
CorMedix	191
Allogene Therapeutics	152
Solid Biosciences	121
BridgeBio Oncology Therapeutics	92
Aclaris Therapeutics	73
Zevra Therapeutics	61
Design Therapeutics	54
Crescent Biopharma	44